Smith & Nephew releases transcript of Q2/H1 2026 results presentation

Reuters2026/08/06 16:04

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!

A welcome pack worth 6200 USDT for new users! Sign up now!

Smith & Nephew discussed Q2/H1 2026 results at an investor presentation attended by CEO Deepak Nath and CFO John Rogers.
Cut 2026 underlying revenue growth outlook to around 4% from softer US Orthopaedics and Advanced Wound Bioactives; Q2 underlying growth was 1.6%.
Kept profit targets unchanged; trading profit was USD 566 million in H1, with 2026 trading profit still guided at about USD 1.3 billion.
Raised 2026 efficiency savings target to about USD 200 million from USD 150 million; tariff refunds seen keeping net tariff impact broadly neutral.
Flagged Q4 growth step-up; Q3 growth seen near Q1 levels, with Q4 at 6%-7% on reported basis, helped by LANDMARK timing.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Smith & Nephew plc published the original content used to generate this news brief on August 06, 2026, and is solely responsible for the information contained therein.

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.

Trade now！

Smith & Nephew releases transcript of Q2/H1 2026 results presentation

You may also like

Crypto prices